Exiqon A/S (NASDAQ OMX: EXQ.CO), a leading supplier of high-value gene
expression analysis products, today announced the appointment of two Centers of
Excellence as part of its new partnership program. The Center of Excellence
partnership program is introduced in response to an increased demand for
Exiqon's products and services.

TATAA Biocenter (www.tataa.com) will market qPCR services based on the Exiqon
microRNA LNA™ qPCR product line and Bioneer A/S (www.bioneer.dk) will market
In-situ Hybridization services based on the Exiqon LNA™ microRNA and mRNA
Detection product line.

“We are pleased to announce the first two Centers of Excellence in our
Partnership program”, said Henrik M Pfundheller, Ph.D., SVP Sales & Marketing
and added: “TATAA and Bioneer are both considered experts within their
respective fields and we are proud to include these two centers in our new
Partnership program”.

Exiqon plans to announce additional Centers of Excellence in the up-coming
months.

Additional information:
Executive Vice President Sales & Marketing, Dr. Elisete Pedrollo, tel. +49 7022
604 333
(cell: +49 170 762 5008)
Senior Vice President Sales & Marketing, Dr. Henrik M. Pfundheller, tel. +45
4565 0420
(cell: +45 4090 2106).

See the full press release in the attached PDF or at
www.exiqon.com/investor/portal.

PressRelease_June2011_CoE_Tataa_Bioneer.docx